Orgenesis Inc.
$0.59
+0.10 (+19.19%)
Open
Prev. Close
$0.49
Day Low
Day High
52W Low
$0.02
52W High
$5.89
Market Cap
$0.00B
Volume
0.00M
Orgenesis Inc. (ORGS) CEO Vered Caplan on Q1 2021 Results - Earnings Call Transcript
ORGS Stock: Over 10% Increase Intraday Explanation
Orgenesis reports four-fold increase in revenue in 1Q as it continues to grow its POCare strategy
ORGS Stock: 14.06% Increase Pre-Market (From $4.48 To $5.11) Explanation
Orgenesis reaches milestone with US FDA approval of Tissue Genesis Icellator2 pilot trial
Orgenesis to collaborate with Bambino Gesù Children's Hospital in Rome on new therapy centre
Orgenesis to collaboration with Bambino Gesù Children's Hospital in Rome on new therapy centre